Intuitive Surgical, Inc. $ISRG Stock: Park Avenue Securities LLC Decreases Stake

Park Avenue Securities LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.5% during the third quarter, Holdings Channel.com reports. The firm owned 14,424 shares of the medical equipment provider’s stock after selling 1,878 shares during the period. Park Avenue Securities LLC’s holdings in Intuitive Surgical were worth $5,865,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ISRG. Bank of New York Mellon Corp acquired a new stake in Intuitive Surgical in the 2nd quarter valued at $1,335,753,000. Arrowstreet Capital Limited Partnership raised its holdings in Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after buying an additional 1,027,475 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in Intuitive Surgical by 55.8% during the third quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock worth $633,505,000 after buying an additional 558,099 shares during the last quarter. Amundi lifted its stake in shares of Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after buying an additional 193,096 shares in the last quarter. Finally, Temasek Holdings Private Ltd lifted its stake in shares of Intuitive Surgical by 416.4% in the first quarter. Temasek Holdings Private Ltd now owns 227,211 shares of the medical equipment provider’s stock valued at $104,742,000 after buying an additional 183,211 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly bullish on ISRG. The consensus rating is “Moderate Buy,” with an average price target of $493.54, while Zacks recently upgraded the stock to “Strong Buy.” Raymond James and BTIG also reiterated positive ratings. Wall Street Views on Intuitive Surgical
• Positive Sentiment: Intuitive Surgical’s latest quarter showed solid demand: revenue rose 21.7% year over year to $3.05 billion, exceeding estimates, while earnings of $3.00 per share beat the $2.65 consensus. This supports the long-term growth case for its da Vinci robotic-surgery business. Intuitive Surgical Earnings and Valuation
• Neutral Sentiment: Recent performance has been mixed: the stock has rebounded over the past one to three months, but remains below its prior-year level. Investors are assessing whether continued procedure growth and higher estimates can justify ISRG’s premium valuation.
• Negative Sentiment: Several insiders reported stock sales, including EVP Mark Brosius, SVP Patricia Wadors, former CEO Gary Guthart and insider Fredrik Widman. Brosius sold shares in two transactions, while Guthart’s reported sale was approximately $9.1 million. The trades were made under pre-arranged Rule 10b5-1 plans, reducing their signaling value, but the volume of selling may weigh on sentiment. Gary Guthart Insider Sale
• Negative Sentiment: Despite the earnings beat, lower net income and earnings-per-share comparisons have highlighted margin pressure. With ISRG trading at a high earnings multiple, investors may be particularly sensitive to any slowdown in profitability or procedure growth. Why Intuitive Surgical’s Strong Quarter Spooked Investors

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Leerink Partners set a $503.00 price target on Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 21st. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 22nd. UBS Group reissued a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $493.54.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 4,047 shares of the business’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $453.21, for a total value of $1,834,140.87. Following the transaction, the vice president directly owned 1,026 shares in the company, valued at $464,993.46. The trade was a 79.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy Ladd sold 400 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the director directly owned 251 shares of the company’s stock, valued at $95,129. This represents a 61.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 38,806 shares of company stock valued at $16,824,795. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $444.18 on Thursday. The company has a market capitalization of $153.97 billion, a price-to-earnings ratio of 53.71, a PEG ratio of 3.12 and a beta of 1.46. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The company has a 50-day simple moving average of $399.37 and a two-hundred day simple moving average of $435.44.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. Intuitive Surgical’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same period last year, the company posted $2.40 earnings per share. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.